Geode Capital Management, LLC Summit Therapeutics Inc. Transaction History

Geode Capital Management, LLC

  • $1.52 Trillion
  • Q3 2025

A detailed history of Geode Capital Management, LLC transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 3,132,735 shares of SMMT stock, worth $57.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,132,735
Previous 2,934,815 6.74%
Holding current value
$57.1 Million
Previous $62.5 Million 3.99%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025
BUY
$17.61 - $30.02 $3.49 Million - $5.94 Million
197,920 Added 6.74%
3,132,735 $64.9 Million
Q2 2025

Aug 08, 2025
SELL
$16.64 - $36.7 $5.83 Million - $12.8 Million
-350,067 Reduced 10.66%
2,934,815 $62.5 Million
Q1 2025

May 13, 2025
BUY
$16.65 - $23.76 $1.4 Million - $2 Million
84,035 Added 2.63%
3,284,882 $63.4 Million
Q4 2024

Feb 12, 2025
BUY
$17.52 - $23.46 $1.77 Million - $2.37 Million
101,039 Added 3.26%
3,200,847 $57.1 Million
Q3 2024

Nov 12, 2024
BUY
$6.89 - $31.93 $936,909 - $4.34 Million
135,981 Added 4.59%
3,099,808 $67.9 Million
Q2 2024

Aug 09, 2024
SELL
$2.39 - $10.92 $450,665 - $2.06 Million
-188,563 Reduced 5.98%
2,963,827 $23.1 Million
Q1 2024

May 13, 2024
BUY
$2.55 - $5.07 $170,146 - $338,290
66,724 Added 2.16%
3,152,390 $13.1 Million
Q4 2023

Feb 13, 2024
BUY
$1.67 - $2.83 $214,767 - $363,946
128,603 Added 4.35%
3,085,666 $8.05 Million
Q3 2023

Nov 13, 2023
BUY
$1.54 - $2.42 $427,741 - $672,164
277,754 Added 10.37%
2,957,063 $5.53 Million
Q2 2023

Aug 11, 2023
BUY
$1.32 - $2.81 $2.1 Million - $4.47 Million
1,590,328 Added 146.04%
2,679,309 $6.73 Million
Q1 2023

May 15, 2023
BUY
$1.38 - $5.41 $851,885 - $3.34 Million
617,308 Added 130.88%
1,088,981 $1.91 Million
Q4 2022

Feb 13, 2023
BUY
$0.68 - $5.31 $100,219 - $782,593
147,381 Added 45.45%
471,673 $2 Million
Q3 2022

Nov 14, 2022
BUY
$0.89 - $1.63 $240,243 - $439,997
269,937 Added 496.62%
324,292 $385,000
Q2 2022

Aug 12, 2022
SELL
$0.92 - $2.38 $186,484 - $482,428
-202,701 Reduced 78.85%
54,355 $54,000
Q1 2022

May 13, 2022
BUY
$2.0 - $3.45 $16,470 - $28,410
8,235 Added 3.31%
257,056 $629,000
Q4 2021

Feb 11, 2022
SELL
$2.45 - $5.64 $6,529 - $15,030
-2,665 Reduced 1.06%
248,821 $669,000
Q3 2021

Nov 12, 2021
BUY
$4.83 - $8.27 $144,383 - $247,215
29,893 Added 13.49%
251,486 $1.26 Million
Q2 2021

Aug 13, 2021
BUY
$5.15 - $8.46 $908,346 - $1.49 Million
176,378 Added 390.09%
221,593 $1.65 Million
Q1 2021

May 12, 2021
BUY
$5.17 - $11.19 $133,406 - $288,746
25,804 Added 132.93%
45,215 $265,000
Q3 2020

Nov 13, 2020
BUY
$3.08 - $3.8 $59,785 - $73,761
19,411 New
19,411 $66,000

Others Institutions Holding SMMT

# of Institutions
267
Shares Held
94.2M
Call Options Held
4.72M
Put Options Held
4.03M
View Full List

About Summit Therapeutics Inc.

SMMT Quotes by TradingView
  • Ticker SMMT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 201,215,008
  • Market Cap $3.67B
  • Description
  • Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...
More about SMMT
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email